World's Best Scientists 2026 revealed!
Ann-Mari Svennerholm

Ann-Mari Svennerholm

D-Index & Metrics

Immunology

D-Index
98
Citations
28750
World Ranking
800
National Ranking
13

Medicine

D-Index
99
Citations
28970
World Ranking
8700
National Ranking
172

Ann-Mari Svennerholm publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ann-Mari Svennerholm sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 397 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ann-Mari Svennerholm D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ann-Mari Svennerholm sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 98 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ann-Mari Svennerholm is affiliated with the University of Gothenburg in Sweden. Their research primarily focuses on the study of Escherichia coli and related infectious diseases, with a broad engagement in biochemistry, genetics, molecular biology, and medicine.

Their scholarly output encompasses work mainly in the fields of Endocrinology, Infectious Diseases, and Molecular Medicine, alongside contributions related to nutrition, dietetics, and public health.

The scientist has contributed to a range of topics including:

  • Escherichia coli research studies
  • Viral gastroenteritis research and epidemiology
  • Antibiotic resistance in bacteria
  • Child nutrition and water access
  • Travel-related health issues
  • Enterobacteriaceae and Cronobacter research
  • Vaccine coverage and hesitancy

Ann-Mari Svennerholm's recent published papers include:

  • Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants, 2021, Vaccine
  • Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access, 2021, Vaccine
  • Colonization factors of human and animal-specific enterotoxigenic Escherichia coli (ETEC), 2023, Trends in Microbiology
  • Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa, 2023, Journal of Travel Medicine
  • Clinical aspects of heat-labile and heat-stable toxin-producing enterotoxigenic Escherichia coli: A prospective study among Finnish travellers, 2020, Travel Medicine and Infectious Disease

Their frequent co-authors include:

  • Astrid von Mentzer
  • Nils Carlin
  • Anna Lundgren
  • Roma Chilengi
  • Firdausi Qadri

Ann-Mari Svennerholm's work has appeared predominantly in the following publication venues:

  • Vaccine
  • Microorganisms
  • Trends in Microbiology
  • Journal of Travel Medicine
  • The Journal of Infectious Diseases

Best Publications

  • ENTEROTOXIGENIC ESCHERICHIA COLI IN DEVELOPING COUNTRIES: EPIDEMIOLOGY, MICROBIOLOGY, CLINICAL FEATURES, TREATMENT, AND PREVENTION

    Firdausi Qadri;Ann Mari Svennerholm;A. S.G. Faruque;R. Bradley Sack

  • Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up

    J.D Clemens;D.A Sack;J.R Harris;F van Loon

  • Colonization factors of human enterotoxigenic Escherichia coli (ETEC)

    Wim Gaastra;Ann-Mari Svennerholm

  • Cross-Protection by B Subunit-Whole Cell Cholera Vaccine Against Diarrhea Associated with Heat-Labile Toxin-Producing Enterotoxigenic Escherichia coli: Results of a Large-Scale Field Trial

    John D. Clemens;David A. Sack;Jeffrey R. Harris;J. Chakraborty

  • Field trial of oral cholera vaccines in Bangladesh

    John D. Clemens;Jeffrey R. Harris;Jeffrey R. Harris;M. R. Khan;Bradford A. Kay;Bradford A. Kay

  • Local Cytokine Response in Helicobacter pylori-Infected Subjects

    C. Lindholm;M. Quiding-Järbrink;H. Lönroth;A. Hamlet

  • Identification ofEscherichia coli heat-labile enterotoxin by means of a ganglioside immunosorbent assay (GM1-ELISA) procedure

    Ann-Mari Svennerholm;Jan Holmgren

  • Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals.

    Anna Lundgren;Elisabeth Suri-Payer;Karin Enarsson;Ann-Mari Svennerholm

  • Protection against Cholera in Breast-Fed Children by Antibodies in Breast Milk

    Glass Ri;Svennerholm Am;Stoll Bj;Khan Mr

  • Mucosal FOXP3-Expressing CD4+ CD25high Regulatory T Cells in Helicobacter pylori-Infected Patients

    Anna Lundgren;Erika Strömberg;Åsa Sjöling;Catharina Lindholm

  • PREDISPOSITION FOR CHOLERA OF INDIVIDUALS WITH O BLOOD GROUP POSSIBLE EVOLUTIONARY SIGNIFICANCE

    Roger I. Glass;Jan Holmgren;Charles E. Haley;M. R. Khan

  • Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh.

    G. Balakrish Nair;Firdausi Qadri;Jan Holmgren;Ann Mari Svennerholm

  • Mucosal Antitoxic and Antibacterial Immunity after Cholera Disease and after Immunization with a Combined B Subunit-Whole Cell Vaccine

    Ann Mari Svennerholm;Ann Mari Svennerholm;Ann Mari Svennerholm;Marianne Jertborn;Marianne Jertborn;Marianne Jertborn;Leif Gothefors;A. M.M.M. Karim;A. M.M.M. Karim;A. M.M.M. Karim

  • Mucosal Immunity: Implications for Vaccine Development

    Jan Holmgren;Cecil Czerkinsky;Nils Lycke;Ann-Mari Svennerholm

  • Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells.

    C Svanborg-Edén;A M Svennerholm

  • Seroepidemiological Studies of El Tor Cholera in Bangladesh: Association of Serum Antibody Levels with Protection

    Roger I. Glass;Ann-Mari Svennerholm;M. R. Khan;Shamsul Huda

  • Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distribution

    Astrid von Mentzer;Thomas Richard Connor;Lothar H. Wieler;Torsten Semmler

  • Prevalence of Toxin Types and Colonization Factors in Enterotoxigenic Escherichia coli Isolated during a 2-Year Period from Diarrheal Patients in Bangladesh

    Firdausi Qadri;Swadesh Kumar Das;A. S.G. Faruque;George J. Fuchs

  • Disease Burden Due to Enterotoxigenic Escherichia coli in the First 2 Years of Life in an Urban Community in Bangladesh

    Firdausi Qadri;Amit Saha;Tanvir Ahmed;Abdullah Al Tarique

  • Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.

    Jan Holmgren;Jenni Adamsson;Fabienne Anjuère;John Clemens

  • Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits

    J. L. Sanchez;B. Vasquez;R. E. Begue;R. Meza

  • Duodenal Helicobacter pylori infection differs in cagA genotype between asymptomatic subjects and patients with duodenal ulcers

    Annika Hamlet;Ann Catrin Thoreson;Ola Nilsson;Ann Mari Svennerholm

Frequent Co-Authors

Jan Holmgren
Jan Holmgren University of Gothenburg
Firdausi Qadri
Firdausi Qadri International Centre for Diarrhoeal Disease Research
David A. Sack
David A. Sack Johns Hopkins University
John D. Clemens
John D. Clemens University of California, Los Angeles
Wim Gaastra
Wim Gaastra Utrecht University
Thomas F. Wierzba
Thomas F. Wierzba Wake Forest University
Alejandro Cravioto
Alejandro Cravioto National Autonomous University of Mexico
Barbara J. Stoll
Barbara J. Stoll The University of Texas Health Science Center at Houston
Stephen B. Calderwood
Stephen B. Calderwood Massachusetts General Hospital
Edward T. Ryan
Edward T. Ryan Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to diverse healthcare careers, including advanced nursing roles that integrate immunological knowledge. For those interested in clinical practice, pursuing nurse practitioner programs online can be a practical route. Exploring the easiest fnp program options may help students find a manageable pathway to becoming a Family Nurse Practitioner, which complements strong immunology backgrounds.

Mental health nursing fields also align closely with immunology research, especially considering the immune system’s role in neuropsychiatric disorders. The best online pmhnp programs focus on clinical placements, providing valuable hands-on experience essential for psychiatric mental health nurse practitioners.

Cost is often a key consideration for students. Fortunately, some of the cheapest pmhnp programs online offer quality education without financial strain. Finding affordable programs can make advanced degrees more attainable while building a strong foundational knowledge in immunology-related health fields.

Career outlooks are promising for those earning advanced nursing degrees. Understanding how much do dnp nurses make can guide candidates in making informed decisions about their education and career trajectory, balancing passion for immunology with potential earnings.

Best Scientists Citing Ann-Mari Svennerholm

Trending Scientists

Recently Published Articles